These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27473943)

  • 1. High levels of brain-derived neurotrophic factor are associated with treatment adherence among crack-cocaine users.
    Scherer JN; Schuch S; Ornell F; Sordi AO; Bristot G; Pfaffenseller B; Kapczinski F; Kessler FHP; Fumagalli F; Pechansky F; von Diemen L
    Neurosci Lett; 2016 Sep; 630():169-175. PubMed ID: 27473943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal.
    Sordi AO; Pechansky F; Kessler FH; Kapczinski F; Pfaffenseller B; Gubert C; de Aguiar BW; de Magalhães Narvaez JC; Ornell F; von Diemen L
    Psychopharmacology (Berl); 2014 Oct; 231(20):4031-9. PubMed ID: 24676990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in biomarkers of crack-cocaine adolescent users before/after abstinence.
    Pianca TG; Rosa RL; Ceresér KMM; de Aguiar BW; de Abrahão RC; Lazzari PM; Kapczinski F; Pechansky F; Rohde LA; Szobot CM
    Drug Alcohol Depend; 2017 Aug; 177():207-213. PubMed ID: 28618284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of childhood trauma on BDNF and TBARS during crack-cocaine withdrawal.
    Sordi AO; von Diemen L; Kessler FH; Schuch S; Ornell F; Kapczinski F; Pfaffenseller B; Gubert C; Wollenhaupt-Aguiar B; Salum GA; Pechansky F
    Braz J Psychiatry; 2020 Apr; 42(2):214-217. PubMed ID: 31826099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal.
    von Diemen L; Kapczinski F; Sordi AO; de Magalhães Narvaez JC; Guimarães LS; Kessler FH; Pfaffenseller B; de Aguiar BW; de Moura Gubert C; Pechansky F
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):33-40. PubMed ID: 24067327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of oxidative stress and brain-derived neurotrophic factor levels related to crack-use detoxification.
    Hirsch GE; Jaskulski M; Hamerski HM; Porto FG; da Silva B; Aita CAM; Kroker K; de Bem Silveira G; Silveira PCL; Santos GT; Klafke JZ; Viecili PRN
    Neurosci Lett; 2018 Mar; 670():62-68. PubMed ID: 29374540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TBARS and BDNF levels in newborns exposed to crack/cocaine during pregnancy: a comparative study.
    Mardini V; Rohde LA; Ceresér KM; Gubert CM; Silva EGD; Xavier F; Parcianello R; Röhsig LM; Pechansky F; Szobot CM
    Braz J Psychiatry; 2017; 39(3):263-266. PubMed ID: 28273279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-Derived Neurotrophic Factor and Delayed Verbal Recall in Crack/Cocaine Dependents.
    Viola TW; Tractenberg SG; Kluwe-Schiavon B; Levandowski ML; Sanvicente-Vieira B; Wearick-Silva LE; de Azeredo LA; Teixeira AL; Grassi-Oliveira R
    Eur Addict Res; 2015; 21(5):273-8. PubMed ID: 26022436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum BDNF levels increase during early drug withdrawal in alcohol and crack cocaine addiction.
    Ornell F; Scherer JN; Schuch JB; Sordi AO; Halpern SC; Rebelatto FP; Bristot G; Kapczinski F; Roglio VS; Pechansky F; Kessler FHP; von Diemen L
    Alcohol; 2023 Sep; 111():1-7. PubMed ID: 37037287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of crack cocaine addiction and stress-related genes on peripheral BDNF levels.
    Rovaris DL; Schuch JB; Grassi-Oliveira R; Sanvicente-Vieira B; da Silva BS; Walss-Bass C; Müller D; Stolf AR; von Diemen L; Ceresér KMM; Pianca TG; Szobot CM; Kessler FHP; Roman T; Bau CHD
    J Psychiatr Res; 2017 Jul; 90():78-85. PubMed ID: 28237884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence.
    Corominas-Roso M; Roncero C; Eiroa-Orosa FJ; Gonzalvo B; Grau-Lopez L; Ribases M; Rodriguez-Cintas L; Sánchez-Mora C; Ramos-Quiroga JA; Casas M
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1078-84. PubMed ID: 23021567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum brain-derived neurotrophic factor levels and cocaine-induced transient psychotic symptoms.
    Corominas-Roso M; Roncero C; Eiroa-Orosa FJ; Ribasés M; Barral C; Daigre C; Martínez-Luna N; Sánchez-Mora C; Ramos-Quiroga JA; Casas M
    Neuropsychobiology; 2013; 68(3):146-55. PubMed ID: 24051573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in brain-derived neurotrophic factor (BDNF) during abstinence could be associated with relapse in cocaine-dependent patients.
    Corominas-Roso M; Roncero C; Daigre C; Grau-Lopez L; Ros-Cucurull E; Rodríguez-Cintas L; Sanchez-Mora C; Lopez MV; Ribases M; Casas M
    Psychiatry Res; 2015 Feb; 225(3):309-14. PubMed ID: 25592977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral toxicity in crack cocaine use disorders.
    Narvaez JC; Magalhães PV; Fries GR; Colpo GD; Czepielewski LS; Vianna P; Chies JA; Rosa AR; Von Diemen L; Vieta E; Pechansky F; Kapczinski F
    Neurosci Lett; 2013 Jun; 544():80-4. PubMed ID: 23597759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress.
    Viola TW; Tractenberg SG; Levandowski ML; Pezzi JC; Bauer ME; Teixeira AL; Grassi-Oliveira R
    J Psychiatry Neurosci; 2014 May; 39(3):206-14. PubMed ID: 24331739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor in substance use disorders: A systematic review and meta-analysis.
    Ornell F; Hansen F; Schuch FB; Pezzini Rebelatto F; Tavares AL; Scherer JN; Valerio AG; Pechansky F; Paim Kessler FH; von Diemen L
    Drug Alcohol Depend; 2018 Dec; 193():91-103. PubMed ID: 30347311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity.
    Pedraz M; Martín-Velasco AI; García-Marchena N; Araos P; Serrano A; Romero-Sanchiz P; Suárez J; Castilla-Ortega E; Barrios V; Campos-Cloute R; Ruiz JJ; Torrens M; Chowen JA; Argente J; de la Torre R; Santín LJ; Villanúa MÁ; Rodríguez de Fonseca F; Pavón FJ
    PLoS One; 2015; 10(3):e0118610. PubMed ID: 25734326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic Disadvantage Moderates the Association between Peripheral Biomarkers and Childhood Psychopathology.
    Mansur RB; Cunha GR; Asevedo E; Zugman A; Zeni-Graiff M; Rios AC; Sethi S; Maurya PK; Levandowski ML; Gadelha A; Pan PM; Stertz L; Belangero SI; Kauer-Sant' Anna M; Teixeira AL; Mari JJ; Rohde LA; Miguel EC; McIntyre RS; Grassi-Oliveira R; Bressan RA; Brietzke E
    PLoS One; 2016; 11(8):e0160455. PubMed ID: 27489945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early discharge predictors among inpatients crack cocaine users.
    Klein E; Ornell F; Roglio VS; Scherer JN; Sordi AO; Schuch JB; Kessler FHP; Diemen LV
    Trends Psychiatry Psychother; 2023; 45():e20210401. PubMed ID: 34898144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes: a prospective study.
    D'Sa C; Fox HC; Hong AK; Dileone RJ; Sinha R
    Biol Psychiatry; 2011 Oct; 70(8):706-711. PubMed ID: 21741029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.